13F Holdings
中文EN

Opaleye Management Inc.

BOSTON MA · SEC CIK 0001595855

2026Q22026Q1 9 earlier quarters 🔒
$1.10B2026Q2 reported value
58Positions
64.8%Top 10 weight · largest 17.7%
11 / 9New / sold out
Reported value over time$1.10B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

LQDA 17.7%
ETON 9.4%
HROW 9.2%
IRON 5.7%
URGN 4.8%
APOGEE THERAPE 4.7%
MGTX 4.3%
SOL-GEL TECHNO 3.4%
RZLT 3.0%
TGTX 2.7%

2026Q2 top buys estimated at quarter-end value

IRON Added+$31.74M
IMMX New+$24.18M
MGTX Added+$19.28M
GLUE New+$18.03M
REPL New+$15.33M

2026Q2 top sells estimated at quarter-end value

CATX Sold out-$19.49M
HROW Reduced-$18.36M
LQDA Reduced-$7.77M
SANUWAVE HEALTH Reduced-$6.75M
JBIO Reduced-$6.28M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
LQDA LIQUIDIA CORPORATION $195.14M17.67%2,447,500 -97,500-3.8% -$7.77M Reduced
ETON ETON PHARMACEUTICALS INC $103.53M9.38%2,860,000 00.0% — Unchanged
HROW HARROW INC $101.93M9.23%2,400,000 -432,230-15.3% -$18.36M Reduced
IRON DISC MEDICINE INC $62.53M5.66%855,000 434,000103.1% $31.74M Added
URGN UROGEN PHARMA LTD $52.99M4.80%1,439,996 9,9960.7% $367,853 Added
— APOGEE THERAPEUTICS INC $51.76M4.69%390,000 00.0% — Unchanged
MGTX MEIRAGTX HLDGS PLC $47.96M4.34%3,550,000 1,426,74167.2% $19.28M Added
— SOL-GEL TECHNOLOGIES LTD $37.07M3.36%500,000 00.0% — Unchanged
RZLT REZOLUTE INC $32.76M2.97%6,300,000 00.0% — Unchanged
TGTX TG THERAPEUTICS INC $29.39M2.66%535,000 00.0% — Unchanged
IMMX IMMIX BIOPHARMA INC $24.18M2.19%2,345,000 2,345,000— $24.18M New
CBIO CRESCENT BIOPHARMA INC. $23.75M2.15%1,319,351 6,7360.5% $121,248 Added
STOK STOKE THERAPEUTICS INC $22.90M2.07%700,000 00.0% — Unchanged
— ALPHA COGNITION INC $20.91M1.89%2,895,467 333,51713.0% $2.41M Added
EWTX EDGEWISE THERAPEUTICS INC $20.32M1.84%500,000 00.0% — Unchanged
RVMD REVOLUTION MEDICINES INC $18.73M1.70%100,000 00.0% — Unchanged
GLUE MONTE ROSA THERAPEUTICS INC $18.03M1.63%745,000 745,000— $18.03M New
ALMS ALUMIS INC $15.48M1.40%550,000 00.0% — Unchanged
CDXS CODEXIS INC $15.33M1.39%6,785,000 00.0% — Unchanged
REPL REPLIMUNE GROUP INC $15.33M1.39%1,384,993 1,384,993— $15.33M New
— XOMA ROYALTY CORPORATION $14.38M1.30%338,374 38,37412.8% $1.63M Added
MBX MBX BIOSCIENCES INC $14.35M1.30%260,000 00.0% — Unchanged
RYTM RHYTHM PHARMACEUTICALS INC $13.60M1.23%122,500 -500-0.4% -$55,515 Reduced
EDIT EDITAS MEDICINE INC $12.51M1.13%3,861,930 1,934,933100.4% $6.27M Added
PTGX PROTAGONIST THERAPEUTICS INC $12.26M1.11%100,000 00.0% — Unchanged
CABA CABALETTA BIO INC $12.02M1.09%3,863,800 2,483,800180.0% $7.72M Added
QTTB Q32 BIO INC $11.86M1.07%931,000 -325,228-25.9% -$4.14M Reduced
ANNX ANNEXON INC $9.79M0.89%1,714,451 -617,310-26.5% -$3.52M Reduced
VSTM VERASTEM INC $6.88M0.62%1,800,000 1,800,000— $6.88M New
ZNTL ZENTALIS PHARMACEUTICALS INC $6.85M0.62%1,412,656 00.0% — Unchanged
RLMD RELMADA THERAPEUTICS INC $6.47M0.59%935,000 00.0% — Unchanged
OCUL OCULAR THERAPEUTIX INC $5.89M0.53%600,000 00.0% — Unchanged
TRVI TREVI THERAPEUTICS INC $5.78M0.52%310,000 -35,100-10.2% -$654,615 Reduced
BBOT BRIDGEBIO ONCOLOGY THERAPEUT $5.33M0.48%700,000 646,7181,213.8% $4.93M Added
LYEL LYELL IMMUNOPHARMA INC $4.83M0.44%344,025 264,928334.9% $3.72M Added
IRD OPUS GENETICS INC $4.62M0.42%1,125,000 5,0000.4% $20,550 Added
FDMT 4D MOLECULAR THERAPEUTICS IN $4.45M0.40%334,437 222,146197.8% $2.95M Added
NTLA INTELLIA THERAPEUTICS INC $4.23M0.38%250,000 5,0002.0% $84,600 Added
— VOYAGER THERAPEUTICS INC $4.15M0.38%1,185,000 35,0003.0% $122,500 Added
— BIODESIX INC $4.06M0.37%180,000 -58,047-24.4% -$1.31M Reduced
RCKT ROCKET PHARMACEUTICALS INC $3.42M0.31%1,000,000 45,0004.7% $153,900 Added
JBIO JADE BIOSCIENCES INC $3.22M0.29%145,000 -282,608-66.1% -$6.28M Reduced
— SANUWAVE HEALTH INC $3.06M0.28%306,140 -675,127-68.8% -$6.75M Reduced
— FORTRESS BIOTECH INC $2.72M0.25%890,000 -152,000-14.6% -$465,120 Reduced
— JOURNEY MED CORP $2.48M0.22%350,000 -610,000-63.5% -$4.32M Reduced
PHAT PHATHOM PHARMACEUTICALS INC $2.01M0.18%185,589 185,589— $2.01M New
INBX INHIBRX BIOSCIENCES INC $1.92M0.17%20,291 20,291— $1.92M New
ENTA ENANTA PHARMACEUTICALS INC $1.82M0.17%125,000 00.0% — Unchanged
COAG HEMAB THERAPEUTICS HLDGS INC $1.75M0.16%47,652 47,652— — First reported
TRAX FIRST TRACKS BIOTHERAPEUTICS $1.31M0.12%65,000 65,000— — First reported
CGON CG ONCOLOGY INC $1.26M0.11%17,789 -77,011-81.2% -$5.47M Reduced
BHVN BIOHAVEN LTD $1.16M0.10%77,915 77,915— $1.16M New
AVIR ATEA PHARMACEUTICALS INC $1.09M0.10%235,000 -87,600-27.2% -$407,340 Reduced
— PASITHEA THERAPEUTICS CORP $1.06M0.10%2,050,000 2,050,000— $1.06M New
— ADC THERAPEUTICS SA $749,0000.07%700,000 700,000— $749,000 New
— OKYO PHARMA LTD $562,8060.05%375,204 375,204— $562,806 New
— PALATIN TECHNOLOGIES INC $221,1950.02%20,500 20,500— $221,195 New
— ADAGIO MED HLDGS INC $13,3530.00%18,444 00.0% — Unchanged
CATX PERSPECTIVE THERAPEUTICS INC $00.00%0 -4,675,000-100.0% -$19.49M Sold out
— ASSERTIO HOLDINGS INC $00.00%0 -265,707-100.0% -$5.06M Sold out
STRO SUTRO BIOPHARMA INC $00.00%0 -190,671-100.0% -$4.75M Sold out
TECX TECTONIC THERAPEUTIC INC $00.00%0 -123,000-100.0% -$3.80M Sold out
RIGL RIGEL PHARMACEUTICALS INC $00.00%0 -70,000-100.0% -$1.89M Sold out
— NEXTCURE INC $00.00%0 -141,181-100.0% -$1.51M Sold out
— PERSPECTIVE THERAPEUTICS INC $00.00%0 -200,000-100.0% -$834,000 Sold out
— PROTALIX BIOTHERAPEUTICS INC $00.00%0 -340,000-100.0% -$737,800 Sold out
LBRX LB PHARMACEUTICALS INC $00.00%0 -14,506-100.0% -$357,718 Sold out